These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15714973)

  • 1. [PSA-based parameters].
    Nakashima J
    Nihon Rinsho; 2005 Feb; 63(2):241-6. PubMed ID: 15714973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSA and other tissue kallikreins for prostate cancer detection.
    Stephan C; Jung K; Lein M; Diamandis EP
    Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
    Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
    Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
    Haese A; Graefen M; Palisaar J; Huland E; Huland H
    Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PSA and hK2 in the diagnosis of prostate cancer].
    Alapont Alacreu JM; Navarro Rosales S; Budía Alba A; España Furió F; Morera Martínez F; Jiménez Cruz JF
    Actas Urol Esp; 2008 Jun; 32(6):575-88. PubMed ID: 18655340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular forms of prostate-specific antigen and human kallikrein 2 as possible indicators in prostatic carcinoma diagnosis].
    Lein M; Stephan C; Jung K; Schnorr D; Loening SA
    Urologe A; 2000 Jul; 39(4):313-23. PubMed ID: 10957772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.
    Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Amirkhan A; Horninger W; Klocker H; Mikolajczyk SD
    J Urol; 2003 Dec; 170(6 Pt 1):2181-5. PubMed ID: 14634374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer.
    Karazanashvili G; Abrahamsson PA
    J Urol; 2003 Feb; 169(2):445-57. PubMed ID: 12544286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
    Steuber T; Vickers A; Haese A; Kattan MW; Eastham JA; Scardino PT; Huland H; Lilja H
    Int J Cancer; 2007 Apr; 120(7):1499-504. PubMed ID: 17205511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
    Becker C; Noldus J; Diamandis E; Lilja H
    Crit Rev Clin Lab Sci; 2001 Oct; 38(5):357-99. PubMed ID: 11720279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
    Bryant RJ; Sjoberg DD; Vickers AJ; Robinson MC; Kumar R; Marsden L; Davis M; Scardino PT; Donovan J; Neal DE; Lilja H; Hamdy FC
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
    Haese A; Graefen M; Huland H; Lilja H
    Curr Urol Rep; 2004 Jun; 5(3):231-40. PubMed ID: 15161573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate cancer and prostate specific antigen screening].
    Camici M
    Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
    Bangma CH; van Schaik RH; Blijenberg BG; Roobol MJ; Lilja H; Stenman UH
    Eur J Cancer; 2010 Nov; 46(17):3109-19. PubMed ID: 21047594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of sensitive immunoassays for free and total human glandular kallikrein 2.
    Väisänen V; Eriksson S; Ivaska KK; Lilja H; Nurmi M; Pettersson K
    Clin Chem; 2004 Sep; 50(9):1607-17. PubMed ID: 15247158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.
    Vickers AJ; Cronin AM; Roobol MJ; Savage CJ; Peltola M; Pettersson K; Scardino PT; Schröder FH; Lilja H
    Clin Cancer Res; 2010 Jun; 16(12):3232-9. PubMed ID: 20400522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.
    Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
    Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual prostate-specific antigen (PSA) forms as prostate tumor markers.
    Becker C; Lilja H
    Clin Chim Acta; 1997 Jan; 257(1):117-32. PubMed ID: 9028629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.
    Nam RK; Diamandis EP; Toi A; Trachtenberg J; Magklara A; Scorilas A; Papnastasiou PA; Jewett MA; Narod SA
    J Clin Oncol; 2000 Mar; 18(5):1036-42. PubMed ID: 10694554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.
    Stephan C; Jung K; Lein M; Sinha P; Schnorr D; Loening SA
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1133-47. PubMed ID: 11097220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.